Table 2.

Treatment cycle characteristics of the studied women (n = 72)

Characteristics	Whole cohort	Proper random start
	n = 72	n = 52
Canceled cycles (poor response)	3 (4%)	3 (6%)
Drugs used a
Corrifollitropin 100–150 mcg	69 (100%)	49 (100%)
Total dose of recombinant FSH (IU)	1651 ± 1118	1778 ± 1200
Total N of GnRH antagonist ampoules	5.3 ± 1.2	5.4 ± 1.4
Duration of stimulation (days) a	11.4 ± 1.9	11.5 ± 1.8
N of developed follicles (diameter ≥ 11 mm) a	19.4 ± 10.1	19.8 ± 10.5
N of oocytes retrieved	14.5 ± 9.7	14.7 ± 10.1
N of mature oocytes retrieved (frozen)	10.6 ± 7.9	10.9 ± 8.1
< 10	37 (51%)	27 (52%)
≥ 10	35 (49%)	25 (48%)

^aExcluding canceled cycles